-------- -----------------------------
FORM 3 OMB APPROVAL
-------- -----------------------------
OMB Number: 3235-0104
Expires: December 31, 2001
Estimated average burden
. hours per response 0.5
-----------------------------
U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934,
Section 17(a) of the Public Utility Holding Company Act of 1935 or
Section 30(f) of the Investment Company Act of 1940
------------------------------------------------------------------------------
1. Name and Address of Reporting Person*
Lane Curtis S.
- ----------------------------------------------------------------------------
(Last) (First) (Middle)
65 East 55th St.
- ----------------------------------------------------------------------------
(Street)
New York New York 10022
- ----------------------------------------------------------------------------
(City) (State) (Zip)
- ----------------------------------------------------------------------------
2. Date of Event Requiring Statement (Month/Day/Year)
7/13/00
- ----------------------------------------------------------------------------
3. IRS Identification Number of Reporting Person (Voluntary)
- ----------------------------------------------------------------------------
4. Issuer Name and Ticker or Trading Symbol
ProMedCo Management Company (PMCO)
- ----------------------------------------------------------------------------
5. Relationship of Reporting Person to Issuer (Check all applicable)
[ X ] Director
[ X ] 10% Owner
[ ] Officer (give title Below)
[ ] Other (Specify below)(1)
--------------------------
- ----------------------------------------------------------------------------
6. If Amendment, Date of Original (Month/Day/Year)
- ----------------------------------------------------------------------------
7. Individual or Joint/Group Filing (Check Applicable Line)
[ x ] Form filed by One Reporting Person
[ ] Form filed by More than One Reporting Person
- ----------------------------------------------------------------------------
<TABLE>
<CAPTION>
Table I--Non-Derivative Securities Beneficially Owned
-----------------------------------------------------------------------------------------------------------
1. Title of Security 2. Amount of 3. Ownership 4. Nature of Indirect
(Instr. 4) Securities Form: Beneficial
Beneficially Direct (D) Ownership
Owned or Indirect (Instr. 5)
(Instr. 4) (I) (Instr. 5)
-----------------------------------------------------------------------------------------------------------
<S> <C> <C> <C>
-----------------------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------------------
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*If the Form is filed by more than one reporting person, see instruction 5(b)(v). (Over)
SEC 1473 (3/99)
</TABLE>
<PAGE>
FORM 3 (continued)
<TABLE>
<CAPTION>
Table II--Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
----------------------------------------------------------------------------------------------------------------------------------
1. Title of Derivative Security 2. Date Exercisable and 3. Title and Amount 4. Conversion or 5. Ownership Form of 6. Nature of
(Instr. 4) Expiration Date of Securities Exercise Price Derivative Indirect
(Month/Day/Year) Underlying of Derivative Security: Beneficial
----------------------- Derivative Security Direct (D) Ownership
Date Expiration Security or Indirect (Instr. 5)
Exercisable Date (Instr. 4) (I) (Instr. 5)
------------------------
Title Amount or
Number of
Shares
----------------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C> <C> <C>
----------------------------------------------------------------------------------------------------------------------------------
Series A Convertible 7/13/00 (1) Common Stock 3,090,920 (1) I (3)
Preferred Stock
Series B Convertible 7/13/00 (2) Common Stock 568,175 (2) I (3)
Preferred Stock
</TABLE>
Explanation of Responses:
(1) MTS Investors E, L.P. owns 77,273 shares of the ProMedCo Management
Company's (the "Company") Series A Convertible Preferred Stock, par value
$0.01 per share (the "Series A Preferred Stock"). Each share of Series A
Preferred Stock is convertible at any time at the option of the holder into
such number of fully paid and nonassessable shares of the Company's Common
Stock, par value $0.01 per share (the "Common Stock"), as is determined by
dividing (x) the Series A Liquidation Preference (defined below) as of the
conversion date, by (y) the Series A Conversion Price (defined below) as of
the conversion date. The initial conversion price for Series A Preferred
Stock is $2.50 per share, which is subject to adjustment as provided in the
Certificate of Designation of the Series A Preferred Stock (the "Series A
Conversion Price"). The "Series A Liquidation Preference" is $100.00 per
share (as adjusted for any stock dividends, combinations or splits with respect
to such share), plus an amount equal to all accrued but unpaid dividends
(whether or not declared) on such share.
(2) MTS Investors E, L.P. owns 22,727 shares of the Company's Series B
Convertible Preferred Stock, par value $0.01 per share (the "Series B
Preferred Stock"). Each share of Series B Preferred Stock is convertible at
any time at the option of the holder into such number of fully paid and
nonassessable shares of the Company's Common Stock, par value $0.01 per share
(the "Common Stock"), as is determined by dividing (x) the Series B Liquidation
Preference (defined below) as of the conversion date, by (y) the Series B
Conversion Price (defined below) as of the conversion date. The initial
conversion price for Series B Preferred Stock is $4.00 per share, which is
subject to adjustment as provided in the Certificate of Designation of the
Series B Preferred Stock (the "Series B Conversion Price"). The "Series B
Liquidation Preference" is $100.00 per share (as adjusted for any stock
dividends, combinations or splits with respect to such share), plus an amount
equal to all accrued but unpaid dividends (whether or not declared) on such
share.
(3) MTS Investors, LLC is the general partner of MTS Investors E, L.P., the
direct acquirer of the stock that is the subject of this Form 3. The Reporting
Person is one of two managing members of MTS Investors, LLC. By reason of
the provisions of Rule 16a-1 under the Securities Exchange Act of 1934, the
Reporting Person disclaims any indirect pecuniary interest in the shares.
/s/ Curtis S. Lane 7/21/00
------------------------------------ --------
By: Curtis S. Lane Date
**Intentional misstatements or omissions of facts
constitute Federal Criminal Violations.
See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must
be manually signed. If space provided is insufficient,
See Instruction 6 for procedure.
Potential persons who are to respond to the collection of
information contained in this form are not required to respond
unless the form displays a currently valid OMB Number.
Page 2
<PAGE>
